Cardlytics (CDLX) Shares Outstanding (Diluted Average) (2017 - 2025)
Historic Shares Outstanding (Diluted Average) for Cardlytics (CDLX) over the last 8 years, with Q3 2025 value amounting to $53.5 million.
- Cardlytics' Shares Outstanding (Diluted Average) rose 692.61% to $53.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 692.61%. This contributed to the annual value of $48.4 million for FY2024, which is 3253.95% up from last year.
- As of Q3 2025, Cardlytics' Shares Outstanding (Diluted Average) stood at $53.5 million, which was up 692.61% from $52.8 million recorded in Q2 2025.
- In the past 5 years, Cardlytics' Shares Outstanding (Diluted Average) registered a high of $53.5 million during Q3 2025, and its lowest value of $29.3 million during Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $37.0 million (2022), whereas its average is $40.4 million.
- Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first crashed by 123.17% in 2023, then skyrocketed by 4064.22% in 2024.
- Cardlytics' Shares Outstanding (Diluted Average) (Quarter) stood at $33.1 million in 2021, then grew by 0.96% to $33.4 million in 2022, then rose by 9.18% to $36.5 million in 2023, then skyrocketed by 32.54% to $48.4 million in 2024, then rose by 10.61% to $53.5 million in 2025.
- Its last three reported values are $53.5 million in Q3 2025, $52.8 million for Q2 2025, and $51.9 million during Q1 2025.